ABCELLERA BIOLOGICS INC revenue for the last year amounted to 34.45 M EUR, the most of which — 34.45 M EUR — came from its highest performing source at the moment, Antibodies, the year earlier bringing 453.56 M EUR. The greatest contribution to the revenue figure was made by Canada — last year it brought ABCELLERA BIOLOGICS INC 32.62 M EUR, and the year before that — 452.42 M EUR.